Delfi Diagnostics Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $5.5M
Latest Deal Amount
  • Investors
  • 6

Delfi Diagnostics General Information

Description

Developer of a healthcare system designed for early detection of cancer. The company's system specializes in research and development of an innovative blood test for the detection and interception of cancer when it is curable for the healthcare industry, enabling professionals to cure their patients in an efficient manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Services
Primary Office
  • 301 West 29th Street
  • Suite 100
  • Baltimore, MD 21211
  • United States
+1 (410) 000-0000

Delfi Diagnostics Timeline

20192020
Financing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Delfi Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 13-Aug-2019 $5.5M 00.00 0000 Completed Generating Revenue
1. Accelerator/Incubator 12-Jul-2019 Completed Generating Revenue
To view Delfi Diagnostics’s complete valuation and funding history, request access »

Delfi Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Delfi Diagnostics’s complete cap table history, request access »

Delfi Diagnostics Executive Team (4)

Name Title Board Seat Contact Info
William Stevens Chief Financial Officer
Nicholas Dracopoli Chief Scientific Officer
Rob Scharpf Ph.D Head of Data Science
Victor Velculescu Ph.D Founder, Chief Executive Officer & Board Member
To view Delfi Diagnostics’s complete executive team members history, request access »

Delfi Diagnostics Board Members (2)

Name Representing Role Since
Greg Yap Self Board Member 000 0000
Victor Velculescu Ph.D Self Founder, Chief Executive Officer & Board Member 000 0000
To view Delfi Diagnostics’s complete board members history, request access »

Delfi Diagnostics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AV8 Ventures Venture Capital Minority 000 0000 000000 0
Illumina Ventures Venture Capital Minority 000 0000 000000 0
Menlo Ventures Venture Capital Minority 000 0000 000000 0
Samsara BioCapital Venture Capital Minority 000 0000 000000 0
Windham Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »